Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002073679-26-000048
Filing Date
2026-04-22
Accepted
2026-04-22 14:43:02
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8920
2 exhibita.pdf EX-1 66510
  Complete submission text file 0002073679-26-000048.txt   102339
Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92867 | Film No.: 26883176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114 4158571965
Funicular Funds, LP (Filed by) CIK: 0001937147 (see all company filings)

EIN.: 882460308 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G